BMY vs MCK
Bristol Myers Squibb vs McKesson Corporation — AI-powered side-by-side comparison
| Metric | BMY | MCK |
|---|---|---|
| AI Score | 56 | 63 |
| Price | $65.30 | $856.25 |
| P/E Ratio | 14.39× | 22.16× |
| ROE | 0.4% | -2.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.0% |
| Debt / Equity | 1.93× | -3.97× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 79.6 | 56.8 |
| Beta | 0.235 | 0.315 |
| Expected Upside | +1.4% | +4.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
MCK Full Analysis